Skip to main
AVIR
AVIR logo

Atea Pharmaceuticals (AVIR) Market Capitalization Overview

Market Cap: $270.44M as of Jun 13, 2025

$270.44M
Past Month+$48.79M (22.01%)
As of Jun 13, 2025, Atea Pharmaceuticals (AVIR) has a market capitalization of $270.44M. Over the past 30 days, its market cap has increased by 3.74%, while in the last 12 months, it has decreased by -4.42%.

Market capitalization represents the total value of Atea Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Atea Pharmaceuticals (AVIR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Atea Pharmaceuticals (AVIR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Atea Pharmaceuticals (AVIR) Market Cap History

DateMarket CapChange
Jun 2, 2025$265.30M+3.74%
May 1, 2025$255.73M+4.91%
Apr 1, 2025$243.75M-0.49%
Mar 3, 2025$244.95M-0.68%
Feb 3, 2025$246.64M-14.62%
Jan 2, 2025$288.87M-2.29%

Atea Pharmaceuticals (AVIR) End of Year Market Cap History

DateMarket CapChange
2025$270.44M-4.42%
2024$282.96M+11.19%
2023$254.48M-36.48%
2022$400.62M-46.08%
2021$742.94M-78.48%
2020$3.46B

FAQs About Atea Pharmaceuticals (AVIR) Market Cap

As of Jun 13, 2025, the market capitalization of Atea Pharmaceuticals (AVIR) is $270.44M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Atea Pharmaceuticals’s market capitalization has increased by 22.01%, changing from $221.66M to $270.44M as of Jun 13, 2025.

In the last 3 months, Atea Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Atea Pharmaceuticals’s market capitalization increased from $254.48M in January to $282.96M in December, reflecting a 11.19% change.

In the past five years, Atea Pharmaceuticals (AVIR) has had a compound annual growth rate (CAGR) of -39.36% in market capitalization. This means its market cap has shrunk at an average rate of -39.36% per year.

Atea Pharmaceuticals (AVIR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.